The world's largest maker of HIV/AIDS drugs, GlaxoSmithKline Plc, is suffering a setback in its development of a new kind of AIDS pill. Two cases of serious liver problems in patients taking its experimental drug Aplaviroc are causing the company to terminate further testing

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

The Food and Drug Administration (FDA) approves a new biologic treatment to treat ulcerative colitis. Manufacturer Centocor, Inc. announces that Remicade has received the green light to treat the chronic inflammatory bowel disease.

Remicade's efficiency in the treatment of inflammatory bowel disease is well established. It was first approved in the United States for the treatment of Crohn's disease in 1998.Remicade remains to this day the only anti-tumor necrosis factor therapy indicated for the treatment of Chron's. With this new approval for the treatment of ulcerative colitis, Remicade is now the only biologic indicated for the treatment of both types of inflammatory bowel diseases

The Medicines and Healthcare products Regulatory Agency (MHRA) says traditional Chinese medicine slimming aids may contain potentially harmful substances.

A drug which raises blood pressure and an amphetamine-like stimulant have both been found in slimming aids

A new study reveals new digital mammogram techniques are better than standard X-rays at spotting cancer. The American College of Radiology Imaging Network studied 50,000 patients, finding standard film X-ray mammograms work just as well for most post-menopausal women. Digital mammographies, however, detect up to 28-percent more cancers than standard mammograms in younger women.

Constantine Gatsonis, network statistician for ACRIN and one of the study's researchers says, "The data show that digital mammography is, on average, as good at detecting breast cancer as film mammography -- and in some important subgroups of women, digital performs even better. Neither film nor digital mammography is able to catch every cancer. So, this study data can be used to develop and improve mammography in the coming years